Emerging Therapies for Multiple Myeloma
June 13, 2018
Topics Covered
We invite you to learn more about:
- Treatment advances for multiple myeloma
- Side-effects management
- Long-term and late effects of treatment
- The importance of shared decision making when discussing treatment
Speaker
Larry D. Anderson, Jr, MD, PhD
Associate Professor of Internal Medicine
Director of Myeloma, Waldenström’s, and Amyloidosis Program
Attending, Hematologic Malgnancies/Blood and Marrow Transplantation Program
UT Southwestern Medical Center
Dallas, TX
Audio Replay
Program Materials
Program Support
Support for this program provided by Amgen, Bristol-Myers Squibb, Celgene, and Takeda Oncology.